MAHONEY DAVID L Insider Trading Activity

Average Profitability
42.33%
Insider Buys Quantity
12
Insider Buys Sum
$2.41M
Insider Sells Quantity
9
Insider Sells Sum
$2.63M

Insider Activity of MAHONEY DAVID L

According to the SEC Form 4 filings, MAHONEY DAVID L, being in a position of

  1. director at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 123606 shares for $13.94M,
    over all time since 2004-11-08, has bought 1585601 share for $2.41M, and sold 540926 shares for $18.6M.

Biography of MAHONEY DAVID L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$13,941,9172100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleCorcept Therapeutics Incorporated
CORT
director
103,606
0.096%
$118.25$12.25M-3.15%
2026-06-17SaleCorcept Therapeutics Incorporated
CORT
director
20,000
0.0193%
$84.53$1.69M+36.76%
2025-05-16SaleCorcept Therapeutics Incorporated
CORT
director
27,352
0.0255%
$74.23$2.03M-6.12%
2023-08-14SaleCorcept Therapeutics Incorporated
CORT
director
25,000
0.0245%
$30.95$773,668-12.15%
2017-07-19SaleCorcept Therapeutics Incorporated
CORT
director
16,915
0.0145%
$12.50$211,458+34.63%
2017-07-18SaleCorcept Therapeutics Incorporated
CORT
director
6,091
0.0054%
$12.50$76,139+39.73%
2017-07-13SaleCorcept Therapeutics Incorporated
CORT
director
484
0.0004%
$12.55$6,073+40.4%
2017-07-12SaleCorcept Therapeutics Incorporated
CORT
director
6,510
0.0058%
$12.50$81,375+39.5%
2016-11-11SaleCorcept Therapeutics Incorporated
CORT
director
60,000
0.0336%
$6.03$361,500+12.76%
2015-07-08SaleCorcept Therapeutics Incorporated
CORT
director
67,656
0.0628%
$5.74$388,136-14.91%
2015-03-20SaleCorcept Therapeutics Incorporated
CORT
director
62,350
0.0639%
$5.85$364,748-10.89%
2014-05-09PurchaseCorcept Therapeutics Incorporated
CORT
director
200,000
0.1994%
$1.85$370,420+61.41%
2011-06-03SaleCorcept Therapeutics Incorporated
CORT
director
144,962
0.0864%
$2.50$362,405-30.86%
2010-04-21PurchaseCorcept Therapeutics Incorporated
CORT
director
97,904
0.1643%
$3.33$326,020+22%
2009-10-16PurchaseCorcept Therapeutics Incorporated
CORT
director
279,722
0.4461%
$1.38$386,016+78.79%
2009-02-06PurchaseCorcept Therapeutics Incorporated
CORT
director
571,428
0.7889%
$0.69$392,571+13%
2008-03-25PurchaseCorcept Therapeutics Incorporated
CORT
director
70,609
0.1712%
$2.77$195,587-45.07%
2007-08-16PurchaseCorcept Therapeutics Incorporated
CORT
director
95,238
0.2665%
$2.10$200,000+35.12%
2007-03-30PurchaseCorcept Therapeutics Incorporated
CORT
director
200,000
0.8569%
$1.00$200,000+197.78%
2006-03-01PurchaseCorcept Therapeutics Incorporated
CORT
director
20,000
0.09%
$5.05$100,980-72.73%
Total: 24
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.